Professor Department of Neurology / University of California Los Angeles / Goldberg Migraine Program Los Angeles, California, United States
This is a debate regarding the use of gepants vs. triptans as first line therapies for the acute treatment of migraine. This part of the session will rebut arguments made for the use of gepants ahead of triptans as acute migraine therapies.
Learning Objectives:
Describe the reasons that triptans should be used ahead of gepants for the acute treatment of migraine
Identify characteristics of efficacy, safety, and tolerability of different acute migraine therapies.
Incorporate understanding of the features of acute migraine therapies into clinical practice
